Clinical Trial Update: A Study of the Effect of ONO-8539 on Oesophageal Pain Hypersensitivity in Patients With Non-erosive Reflux Disease [Phase 1]

View source ↗

Summary

The document notes that ONO-8539 completed a Phase 1 trial assessing its effect on esophageal pain hypersensitivity in patients with non-erosive reflux disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Non-erosive Reflux Disease

Drugs mentioned

• ONO-8539

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: GERD | Phase 1 | Status: COMPLETED